Report Summary
Eternity Insights can provide a deep-dive research report highlighting the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Sotalol market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition.
Sotalol market report is based on robust research methodology designed using blend of research approaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Sotalol market is estimated to expand at a considerable growth rate during the forecast period owing to the increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in awareness about diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in the research and development of technologically advanced products leading to increased utilization of Sotalol products across developed and developing countries of the world.
Key Research Highlights: Market Restraints
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Sotalol products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Sotalol market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Sotalol development has been the leading industry trend of Sotalol market
The leading players in the market are focused on developing products which are cost-effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be witnessed from the increased spending on research and development and growing number of new product approvals.
Global Sotalol Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
40mg, 80mg, Other |
| By Application Outlook |
Sustained Ventricular Tachycardia, Atrial Fibrillation/Flutter, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Bayer, GSK, Bristol-Myers Squibb (BMS), Arbor Pharmaceuticals, Cambrex, Arevipharma, Shaanxi Hanjiang Pharmaceutical Group, Samarth Pharma Pvt. Ltd., Cipla Limited |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Bayer
- GSK
- Bristol-Myers Squibb (BMS)
- Arbor Pharmaceuticals
- Cambrex
- Arevipharma
- Shaanxi Hanjiang Pharmaceutical Group
- Samarth Pharma Pvt. Ltd.
- Cipla Limited
Sotalol Market, By Type
Sotalol Market, By Application
- Sustained Ventricular Tachycardia
- Atrial Fibrillation/Flutter
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Sotalol Market Overview
1.1 Sotalol Product Overview
1.2 Sotalol Market Segment by Type
1.2.1 40mg
1.2.2 80mg
1.3 Global Sotalol Market Size by Type
1.3.1 Global Sotalol Sales and Growth by Type
1.3.2 Global Sotalol Sales and Market Share by Type (2014-2019)
1.3.3 Global Sotalol Revenue and Market Share by Type (2014-2019)
1.3.4 Global Sotalol Price by Type (2014-2019)
2 Global Sotalol Market Competition by Company
2.1 Global Sotalol Sales and Market Share by Company (2014-2019)
2.2 Global Sotalol Revenue and Share by Company (2014-2019)
2.3 Global Sotalol Price by Company (2014-2019)
2.4 Global Top Players Sotalol Manufacturing Base Distribution, Sales Area, Product Types
2.5 Sotalol Market Competitive Situation and Trends
2.5.1 Sotalol Market Concentration Rate
2.5.2 Global Sotalol Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Sotalol Company Profiles and Sales Data
3.1 Bayer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Sotalol Product Category, Application and Specification
3.1.3 Bayer Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 GSK
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Sotalol Product Category, Application and Specification
3.2.3 GSK Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Bristol-Myers Squibb (BMS)
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Sotalol Product Category, Application and Specification
3.3.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Arbor Pharmaceuticals
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Sotalol Product Category, Application and Specification
3.4.3 Arbor Pharmaceuticals Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Cambrex
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Sotalol Product Category, Application and Specification
3.5.3 Cambrex Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Arevipharma
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Sotalol Product Category, Application and Specification
3.6.3 Arevipharma Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Shaanxi Hanjiang Pharmaceutical Group
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Sotalol Product Category, Application and Specification
3.7.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Samarth Pharma Pvt. Ltd.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Sotalol Product Category, Application and Specification
3.8.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Cipla Limited
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Sotalol Product Category, Application and Specification
3.9.3 Cipla Limited Sotalol Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
4 Sotalol Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Sotalol Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Sotalol Sales and Revenue by Regions
4.2.1 Global Sotalol Sales and Market Share by Regions (2014-2019)
4.2.2 Global Sotalol Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Sotalol Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Sotalol Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Sotalol Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Sotalol Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Sotalol Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Sotalol Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Sotalol Application/End Users
5.1 Sotalol Segment by Application
5.1.1 Sustained Ventricular Tachycardia
5.1.2 Atrial Fibrillation/Flutter
5.2 Global Sotalol Product Segment by Application
5.2.1 Global Sotalol Sales by Application
5.2.2 Global Sotalol Sales and Market Share by Application (2014-2019)
6 Global Sotalol Market Forecast
6.1 Global Sotalol Sales, Revenue Forecast (2019-2025)
6.1.1 Global Sotalol Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Sotalol Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Sotalol Forecast by Regions
6.2.1 North America Sotalol Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Sotalol Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Sotalol Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Sotalol Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Sotalol Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Sotalol Forecast by Type
6.3.1 Global Sotalol Sales and Revenue Forecast by Type (2019-2025)
6.3.2 40mg Gowth Forecast
6.3.3 80mg Gowth Forecast
6.4 Sotalol Forecast by Application
6.4.1 Global Sotalol Sales Forecast by Application (2019-2025)
6.4.2 Global Sotalol Forecast in Sustained Ventricular Tachycardia
6.4.3 Global Sotalol Forecast in Atrial Fibrillation/Flutter
7 Sotalol Upstream Raw Materials
7.1 Sotalol Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Sotalol Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
